How many sentinel lymph nodes are enough for accurate axillary staging in T1-2 breast cancer?

Journal of Breast Cancer

Volumn 14, Issue 4, 2011, Pages 296-300

  Ban, Eun Jeong ^a   Lee, Jun Sang ^a   Koo, Ja Seung ^a   Park, Seho ^a   Kim, Seung Il ^a   Park, Byeong Woo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Breast neoplasms; False negative rate; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; AXILLARY LYMPH NODE STAGING; BREAST CANCER; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; SENTINEL LYMPH NODE BIOPSY;

EID: 84863037055     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2011.14.4.296     Document Type: Article

References (30)

1. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006;7:983-90.
2. McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000; 18:2560-6.
3. Hoar FJ, Stonelake PS. A prospective study of the value of axillary node sampling in addition to sentinel lymph node biopsy in patients with breast cancer. Eur J Surg Oncol 2003;29:526-31.
4. Krag DN. Minimal access surgery for staging regional lymph nodes: the sentinel-node concept. Curr Probl Surg 1998;35:951-1016.
5. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
6. Dabbs DJ, Johnson R. The optimal number of sentinel lymph nodes for focused pathologic examination. Breast J 2004;10:186-9.
7. McCarter MD, Yeung H, Fey J, Borgen PI, Cody HS 3rd Te breast cancer patient with multiple sentinel nodes: when to stop? J Am Coll Surg 2001;192:692-7.
8. Nathanson SD. Will the true sentinel node please stand? Ann Surg Oncol 1999;6:514-6.
9. Morton DL, Bostick PJ. Will the true sentinel node please stand? Ann Surg Oncol 1999;6:12-4.
10. Harlow SP, Krag DN, Julian TB, Ashikaga T, Weaver DL, Feldman SA, et al. Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg 2005; 241:48-54.
11. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186:275-83.
12. Krag D, Weaver D, Ashikaga T, Mofat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl JMed 1998;339:941-6.
13. Tafra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001;233:51-9.
14. Woznick A, Franco M, Bendick P Benitez PR. Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal? Am J Surg 2006; 191:330-3.
15. Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006;13:491-500.
16. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival fndings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11:927-33.
17. Zakaria S, Degnim AC, Kleer CG, Diehl KA, Cimmino VM, Chang AE, et al. Sentinel lymph node biopsy for breast cancer: how many nodes are enough? J Surg Oncol 2007;96:554-9.
18. Koo BY Jeong SG, Eom TI, Kang HJ, Kim LS. Te number of removed lymph nodes for an acceptable false negative rate in sentinel lymph node biopsy for breast cancer. J Breast Cancer 2009;12:100-5.
19. Choi JE, Park SY, Jeon MH, Kang SH, Bae YK, Lee SJ. Optimal sampling number of sentinel lymph nodes in invasive breast cancer: results of 1,026 sentinel lymph node biopsies done by radioisotope. J Breast Cancer 2011;14(Suppl 1):S37-43.
20. Oh JW, Jung SY Hur H, Lee JD, Kim SI, Kim SH, et al. Te result of evaluation according to radioactivity of sequential sentinel nodes biopsy in breast cancer. J Breast Cancer 2006;9:235-40.
21. Yi M, Meric-Bernstam F, Ross MI, Akins JS, Hwang RF, Lucci A, et al. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer 2008;113:30-7.
22. Povoski SP Young DC, Walker MJ, Carson WE, Yee LD, Agnese DM, et al. Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery. World J Surg Oncol 2007;5:18.
23. Kelley MC, Hansen N, McMasters KM. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg 2004; 188:49-61.
24. Spillane AJ, Brennan ME. Accuracy of sentinel lymph node biopsy in large and multifocal/multicentric breast carcinoma: a systematic review. Eur J Surg Oncol 2011;37:371-85.
25. Gill G; SNAC Trial Group of the Royal Australasian College of Surgeons (RACS) and NHMRC Clinical Trials Centre. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 2009;16:266-75.
26. Martin RC, Edwards MJ, Wong SL, Tuttle TM, Carlson DJ, Brown CM, et al. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study For the University of Louisville Breast Cancer Study Group. Surgery 2000; 128:139-44.
27. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
28. Boxen I, McCready D, Ballinger JR. Sentinel node detection and defnition may depend on the imaging agent and timing. Clin Nucl Med 1999; 24:390-4.
29. Martin RC, Fey J, Yeung H, Borgen PI, Cody HS Highest isotope count does not predict sentinel node positivity in all breast cancer patients. Ann Surg Oncol 2001;8:592-7.
30. Ko SS; Korean Breast Cancer Society Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10 years (1996-2006) using nationwide breast cancer registration on-line program: biannual update. J Surg Oncol 2008;98:318-23.